A bill that would have transferred regulatory oversight of Oklahoma HMOs from the state's health department to its insurance department is effectively dead for this year.
Sen. Brad Henry, a Democrat who is chairman of the Judiciary Committee, declined to hold hearings, saying the health department should have jurisdiction because decisions often are medically related.
Republican Sen. James Williamson filed his bill in response to concerns about the viability of Oklahoma HMOs, which lost $24 million last year.
View the discussion thread.
Our other journal
P&T Journal for November 2014
LETTER TO THE EDITOR
Medications for Parkinson’s Disease
The Changing Roles of P&T Committees
Epilepsy Management: Newer Agents, Unmet Needs, and Future Treatment Strategies
Modest Growth Seen in Epilepsy Market
European Society of Cardiology and Transcatheter Cardiovascular Therapeutics
“Generic: The Unbranding of Modern Medicine,” by Jeremy A. Greene, MD, PhD
Misadministration of IV Insulin Associated With Dose Measurement And Hyperkalemia Treatment
FDA’s Proposed 503B Draft Compounding Guidance Raises Concerns of All Kinds
New Drugs/Drug News
Pharmaceutical Approval Update
Riociguat (Adempas): a Novel Agent For the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension